Corrigendum to “The effects of casein glycomacropeptide on general health status in children with PKU

Pinto, AlexDaly, AnneNewby, CamilleRobotham, AbigailHeales, SimonEaton, SimonAitkenhead, HelenGilmour, KimberlyJackson, RichardAshmore, CatherineEvans, SharonRocha, Júlio CesarIlgaz, FatmaHickson, MaryMacDonald, Anita2025-04-142025-04-142025-051096-7192PURE: 114952377PURE UUID: 6ce3e865-753c-47d3-a64b-1676687551d0Scopus: 105000436862http://hdl.handle.net/10362/182286Publisher Copyright: © 2025 The Author(s)The authors regret typing errors in the abstract where the p-values should be adiponectin (p = 0.049) and total antioxidant capacity (p = 0.028) and in table 2 (page 5), the energy intake for AA should read 1762 (1298–2321) rather than 1762 (1298–1677). The authors would like to apologise for any inconvenience caused.285512engEndocrinology, Diabetes and MetabolismBiochemistryMolecular BiologyGeneticsEndocrinologySDG 3 - Good Health and Well-beingCorrigendum to “The effects of casein glycomacropeptide on general health status in children with PKUother10.1016/j.ymgme.2025.109077A randomized crossover trial” [Molecular Genetics and Metabolism Volume 143, Issue 4, December 2024, 108607] (Molecular Genetics and Metabolism (2024) 143(4), (S1096719224004918), (10.1016/j.ymgme.2024.108607))https://www.scopus.com/pages/publications/105000436862